ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 49 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,286 | -99.9% | 625,504 | +12.2% | 0.00% | 0.0% |
| Q3 2022 | $5,488,000 | +29.0% | 557,683 | +27.7% | 0.00% | 0.0% |
| Q2 2022 | $4,253,000 | +13.2% | 436,864 | +13.3% | 0.00% | +50.0% |
| Q1 2022 | $3,756,000 | +52.3% | 385,614 | +28.5% | 0.00% | +100.0% |
| Q4 2021 | $2,466,000 | – | 300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arena Capital Advisors, LLC- CA | 141,317 | $1,448,499 | 2.02% |
| Atalaya Capital Management LP | 500,000 | $5,115,000 | 1.63% |
| MMCAP International Inc. SPC | 800,000 | $8,184,000 | 1.61% |
| ANGELO GORDON & CO., L.P. | 300,000 | $3,069,000 | 0.77% |
| FIR TREE CAPITAL MANAGEMENT LP | 792,269 | $8,104,912 | 0.64% |
| Castle Creek Arbitrage, LLC | 530,000 | $5,421,900 | 0.60% |
| 683 Capital Management, LLC | 699,000 | $7,150,770 | 0.53% |
| GLAZER CAPITAL, LLC | 850,590 | $8,702 | 0.48% |
| P SCHOENFELD ASSET MANAGEMENT LP | 500,000 | $5,125,000 | 0.45% |
| METEORA CAPITAL, LLC | 366,183 | $3,746,052 | 0.44% |